Austin, TX 7/9/12—Luminex has definitely agreed to acquire molecular diagnostics firm GenturaDx for $50 million in cash, subject to working-capital reconciliation and potential contingent consideration. GenturaDx is in late-stage development of an integrated, automated, real-time PCR system that utilizes a single-use cassette. Luminex plans to integrate its MultiCode-RTx chemistry with the instrument and commercialize assays […]